Clinical Trials

Research has led to progress against many types of cancer:

  • Better Treatments
  • a Lower Chance of Death from the Disease
  • and Improved Quality of Life.

Through research, knowledge about cancer keeps increasing. Scientists are learning more about what causes cancer and are finding new ways to prevent, detect, diagnose, and treat this disease.

Highlands Oncology Group, PA has been participating in clinical trials for over 15 years. The research department started with a small staff of one who performed all duties. Today, our current staff includes a Research Director, 2 Phase I Coordinators, 5 Phase II/III/IV Coordinators, 2 Medical Assistants, 3 Data Managers, and 3 Regulatory Specialist. Typically there are 25-35 open and accruing trials with 3-5 more pending. The trials cover a variety of cancer diagnoses. Highlands Oncology Group, PA has the privilege of being the only community Phase I Oncology clinical site in the state of Arkansas.

Clinical trials are a treatment option for many people living with cancer. The next few pages may help to explain clinical trials and give you something to think about when deciding whether or not to participate.

I5B-MC-JGDPPANCREATIC12/14/2018View Here
WO40181 Breast Cancer, ER+, HER2-Locally advanced or MetastaticBREAST12/14/2018View Here
Tyme-88-Panc Pancreatic CancerPANCREATIC12/14/2018View Here
Platinum Resistant or Refractory Ovarian CancerOVARIAN12/14/2018View Here
CPDR001F2301 Melanoma-Unresectable or MetastaticMELANOMA12/14/2018View Here
CPDR001C2101 NSCLC- stage IIIB or IVLUNG - Non Small Cell Cancer (NSCLC)12/14/2018View Here
B9991025 ADV/MET SOLID TUMOROTHER12/14/2018View Here
I3Y-MC-JPCF BREAST CANCER HR+, HER2 -, high risk, node+, early stage, resectedBREAST12/14/2018View Here
C16029 Relapsed/Refractory Multiple MyelomaMULTIPLE MYELOMA12/14/2018View Here
D419QC00001(Caspian) SCLC Stage IVLUNG - Small Cell Cancer (SCLC)12/14/2018View Here
I3Y-MC-JPBH Breast –Metastatic-Phase 1BREAST12/14/2018View Here
RXDX-101-02 ( STARTRK-2) Locally Advanced TumorsOTHER12/14/2018View Here
M16-298 (MERU) Extensive Stage SCLC - MaintenanceLUNG - Small Cell Cancer (SCLC)12/14/2018View Here
G1T28-03 SCLC Extensive-Stage , 2nd or 3rd line TxLUNG - Small Cell Cancer (SCLC)12/14/2018View Here
M16-289 (TAHOE) Advanced or Metastatic DLL3high SCLC – 2nd LineLUNG - Small Cell Cancer (SCLC)12/14/2018View Here
CX-839-005 Renal Cell Carcinoma – Advanced or MetastaticRENAL CELL12/14/2018View Here
CA 209914 “CheckMate 914” Renal Cell Carcinoma – Previously Untreated, Localized Who Underwent Radical or Partial Nephrectomy and Who Are at High Risk of Relapse.RENAL CELL12/14/2018View Here
I3Y-MC-JPCE NSCLC KRAS and PDL1 positive, stage IVBREAST12/14/2018View Here
GO29527 NSCLC - Stage IB−Stage IIIALUNG - Non Small Cell Cancer (NSCLC)12/14/2018View Here
CA209592 NSCLC-Stage IVLUNG - Non Small Cell Cancer (NSCLC)12/14/2018View Here
VX15/2503-04 NSCLC – Stage IVLUNG - Non Small Cell Cancer (NSCLC)12/14/2018View Here
SWOG S1320 MUTANT MELANOMAMELANOMA12/14/2018View Here
CO39722 UNTREATED ADVANCED WILD-TYPE MELANOMAMELANOMA12/14/2018View Here
UTX-TGR-204 Lymphocytic Leukemia- ChronicLEUKEMIA - Chronic Lymphocytic12/14/2018View Here
BBI-DSP7888-201G Recurrent or Progressive GlioblastomaGLIOBLASTOMA12/14/2018View Here
LSK-AM301 Advanced or Metastatic Gastric CancerOTHER12/14/2018View Here
CLEE011XUS29 HR+ HER2- Breast CancerBREAST12/14/2018View Here
SWOG S1418 TNBC with Residual Invasive CancerBREAST12/14/2018View Here
MM-121-02-02-10 (SHERBOCK) BREAST CANCER-locally advanced or metastatic. ER/PR (+), HER2(-), Heregulin(+).BREAST12/14/2018View Here
BMS CA209-602 Multiple Myeloma Relapsed Or RefractoryMULTIPLE MYELOMA12/14/2018View Here
CA209-592 NSCLC Stage IVLUNG - Non Small Cell Cancer (NSCLC)12/14/2018View Here
WO30070 UNTREATED LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMAOTHER12/14/2018View Here
4010-01-001 Advanced solid TumorsOTHER12/14/2018View Here
CANSTEM 111P Pancreatic AdenocarcinomaPANCREATIC12/14/2018View Here
CO39262 MelanomaMELANOMA12/14/2018View Here
BDX-00146 (INSIGHT)LUNG - Non Small Cell Cancer (NSCLC)12/14/2018View Here
B9991016 Head and Neck, Stage IV,Squamous cell, locally advanced, high risk carcinoma of oral cavity, larynx, hypopharynx, oropharynx.HEAD/NECK12/14/2018View Here
I4D-MC-JTJH SCLC Previously Treated Extensive StageLUNG - Small Cell Cancer (SCLC)12/14/2018View Here
“Vaccination of High Risk Breast Cancer Patients”BREAST12/14/2018View Here
HALO 109-301 PancreaticPANCREATIC12/14/2018View Here
GU 115 / I6A-MC-CBBD Metastatic Castration Resistant Prostate CancerPROSTATE12/14/2018View Here
ML28897-PRO02 Pathway Activated Solid TumorsOTHER12/14/2018View Here